US Stock MarketDetailed Quotes

Quantum BioPharma (QNTM)

Watchlist
  • 6.300
  • -0.120-1.87%
Close Jan 22 16:00 ET
  • 6.420
  • +0.120+1.90%
Pre 08:00 ET
24.21MMarket Cap-0.66P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quantum BioPharma (QNTM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.36%4.66M
41.57%4.91M
50.26%3.39M
-18.84%15.88M
202.91%6.09M
45.48%4.07M
-36.45%3.47M
-75.77%2.25M
-28.65%19.57M
-69.83%2.01M
Selling and administrative expenses
25.26%4.02M
73.36%4.22M
-18.51%1.61M
-29.49%9.31M
-11.66%1.69M
19.42%3.21M
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-31.70%1.92M
-General and administrative expense
25.26%4.02M
73.36%4.22M
-18.51%1.61M
-29.49%9.31M
-11.66%1.69M
19.42%3.21M
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-31.70%1.92M
Research and development costs
-33.51%495.22K
-38.84%549.2K
928.55%1.65M
57.63%6.08M
14,386.34%4.28M
2,358.00%744.8K
-44.24%897.99K
-93.07%160.26K
-44.16%3.86M
-101.11%-29.96K
Depreciation amortization depletion
20.30%145.34K
3.34%141.38K
7.95%129.69K
-80.43%490.57K
-7.70%112.8K
-17.71%120.81K
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-Depreciation and amortization
20.30%145.34K
3.34%141.38K
7.95%129.69K
-80.43%490.57K
-7.70%112.8K
-17.71%120.81K
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
Operating profit
-14.36%-4.66M
-41.57%-4.91M
-50.26%-3.39M
18.84%-15.88M
-202.91%-6.09M
-45.48%-4.07M
36.45%-3.47M
75.77%-2.25M
28.65%-19.57M
69.83%-2.01M
Net non-operating interest income expense
-103.03%-4.66K
-250.77%-144.84K
-277.00%-283.4K
-33.17%525.31K
-24.80%115.64K
-12.01%153.5K
-48.40%96.07K
-41.07%160.11K
146.48%786.06K
-48.72%153.78K
Non-operating interest income
-38.72%100.42K
-13.11%90.73K
-61.04%67.22K
-27.15%572.89K
-14.12%132.08K
-5.86%163.87K
-43.91%104.42K
-36.65%172.52K
113.84%786.36K
-48.74%153.79K
Non-operating interest expense
913.16%105.08K
2,718.87%235.57K
2,724.36%350.62K
15,812.04%47.58K
136,858.33%16.44K
--10.37K
--8.36K
1,761.17%12.41K
-99.39%299
-91.11%12
Other net income (expense)
11.45%-84.75K
-21,187.11%-4.71M
-302,296.54%-5.07M
-19.92%443.19K
152.25%514.89K
-106.41%-95.71K
110.41%22.33K
100.18%1.68K
35.97%553.46K
-3.47%204.12K
Gain on sale of security
5.39%-102.2K
-29,364.89%-6.53M
-19,797.03%-3.77M
-272.22%-293.22K
-151.48%-226.67K
79.14%-108.03K
-96.80%22.33K
104.25%19.15K
-40.80%170.25K
107.74%440.31K
Special income (charges)
-8.69%11.25K
---110.27K
1,159.34%185.13K
116.08%732.42K
412.28%737.57K
--12.32K
--0
96.36%-17.48K
---4.56M
---236.19K
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--4.56M
----
-Less:Other special charges
8.69%-11.25K
--110.27K
-1,159.34%-185.13K
---732.42K
---737.57K
---12.32K
----
--17.48K
----
----
-Write off
----
----
----
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
--6.2K
--1.94M
---1.48M
-99.92%3.99K
----
----
----
----
4,034.69%4.94M
--0
Income before tax
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
Income tax
Net income
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
22.77%-18.23M
73.14%-1.65M
Net income continuous Operations
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
--0
----
Minority interest income
403.70%571.43K
-113.34%-513.26K
13.24%-163.16K
-117.05%-712.81K
62.65%-96.02K
-163.67%-188.16K
-240.58K
-188.05K
-328.41K
-257.05K
Net income attributable to the parent company
-38.98%-5.32M
-197.34%-9.25M
-350.61%-8.58M
20.66%-14.2M
-284.38%-5.36M
-261.11%-3.83M
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
77.32%-1.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.98%-5.32M
-197.34%-9.25M
-350.61%-8.58M
20.66%-14.2M
-284.38%-5.36M
-261.11%-3.83M
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
77.32%-1.39M
Basic earnings per share
71.40%-1.25
37.88%-3.23
-2.92%-3.53
56.16%-13.12
18.97%-2.331
-148.62%-4.37
42.86%-5.2
79.70%-3.43
24.44%-29.93
72.23%-2.8769
Diluted earnings per share
71.40%-1.25
37.88%-3.23
-2.92%-3.53
56.16%-13.12
18.97%-2.331
-148.62%-4.37
42.86%-5.2
79.70%-3.43
24.44%-29.93
72.23%-2.8769
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.36%4.66M41.57%4.91M50.26%3.39M-18.84%15.88M202.91%6.09M45.48%4.07M-36.45%3.47M-75.77%2.25M-28.65%19.57M-69.83%2.01M
Selling and administrative expenses 25.26%4.02M73.36%4.22M-18.51%1.61M-29.49%9.31M-11.66%1.69M19.42%3.21M-11.22%2.44M-66.32%1.97M-17.37%13.2M-31.70%1.92M
-General and administrative expense 25.26%4.02M73.36%4.22M-18.51%1.61M-29.49%9.31M-11.66%1.69M19.42%3.21M-11.22%2.44M-66.32%1.97M-17.37%13.2M-31.70%1.92M
Research and development costs -33.51%495.22K-38.84%549.2K928.55%1.65M57.63%6.08M14,386.34%4.28M2,358.00%744.8K-44.24%897.99K-93.07%160.26K-44.16%3.86M-101.11%-29.96K
Depreciation amortization depletion 20.30%145.34K3.34%141.38K7.95%129.69K-80.43%490.57K-7.70%112.8K-17.71%120.81K-87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K
-Depreciation and amortization 20.30%145.34K3.34%141.38K7.95%129.69K-80.43%490.57K-7.70%112.8K-17.71%120.81K-87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K
Operating profit -14.36%-4.66M-41.57%-4.91M-50.26%-3.39M18.84%-15.88M-202.91%-6.09M-45.48%-4.07M36.45%-3.47M75.77%-2.25M28.65%-19.57M69.83%-2.01M
Net non-operating interest income expense -103.03%-4.66K-250.77%-144.84K-277.00%-283.4K-33.17%525.31K-24.80%115.64K-12.01%153.5K-48.40%96.07K-41.07%160.11K146.48%786.06K-48.72%153.78K
Non-operating interest income -38.72%100.42K-13.11%90.73K-61.04%67.22K-27.15%572.89K-14.12%132.08K-5.86%163.87K-43.91%104.42K-36.65%172.52K113.84%786.36K-48.74%153.79K
Non-operating interest expense 913.16%105.08K2,718.87%235.57K2,724.36%350.62K15,812.04%47.58K136,858.33%16.44K--10.37K--8.36K1,761.17%12.41K-99.39%299-91.11%12
Other net income (expense) 11.45%-84.75K-21,187.11%-4.71M-302,296.54%-5.07M-19.92%443.19K152.25%514.89K-106.41%-95.71K110.41%22.33K100.18%1.68K35.97%553.46K-3.47%204.12K
Gain on sale of security 5.39%-102.2K-29,364.89%-6.53M-19,797.03%-3.77M-272.22%-293.22K-151.48%-226.67K79.14%-108.03K-96.80%22.33K104.25%19.15K-40.80%170.25K107.74%440.31K
Special income (charges) -8.69%11.25K---110.27K1,159.34%185.13K116.08%732.42K412.28%737.57K--12.32K--096.36%-17.48K---4.56M---236.19K
-Less:Impairment of capital assets --------------0------------------4.56M----
-Less:Other special charges 8.69%-11.25K--110.27K-1,159.34%-185.13K---732.42K---737.57K---12.32K------17.48K--------
-Write off ----------------------0--0--0--------
Other non- operating income (expenses) --6.2K--1.94M---1.48M-99.92%3.99K----------------4,034.69%4.94M--0
Income before tax -18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M
Income tax
Net income -18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M79.00%-2.09M22.77%-18.23M73.14%-1.65M
Net income continuous Operations -18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M
Net income discontinuous operations --------------0------------------0----
Minority interest income 403.70%571.43K-113.34%-513.26K13.24%-163.16K-117.05%-712.81K62.65%-96.02K-163.67%-188.16K-240.58K-188.05K-328.41K-257.05K
Net income attributable to the parent company -38.98%-5.32M-197.34%-9.25M-350.61%-8.58M20.66%-14.2M-284.38%-5.36M-261.11%-3.83M43.32%-3.11M80.89%-1.9M24.17%-17.9M77.32%-1.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.98%-5.32M-197.34%-9.25M-350.61%-8.58M20.66%-14.2M-284.38%-5.36M-261.11%-3.83M43.32%-3.11M80.89%-1.9M24.17%-17.9M77.32%-1.39M
Basic earnings per share 71.40%-1.2537.88%-3.23-2.92%-3.5356.16%-13.1218.97%-2.331-148.62%-4.3742.86%-5.279.70%-3.4324.44%-29.9372.23%-2.8769
Diluted earnings per share 71.40%-1.2537.88%-3.23-2.92%-3.5356.16%-13.1218.97%-2.331-148.62%-4.3742.86%-5.279.70%-3.4324.44%-29.9372.23%-2.8769
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -